Arthur F Ryan - Net Worth and Insider Trading
Arthur F Ryan Net Worth
The estimated net worth of Arthur F Ryan is at least $24 Million dollars as of 2024-10-18. Arthur F Ryan is the Director of Regeneron Pharmaceuticals Inc and owns about 17,582 shares of Regeneron Pharmaceuticals Inc (REGN) stock worth over $18 Million. Arthur F Ryan is also the Chairman, CEO and President of Prudential Financial Inc and owns about 52,431 shares of Prudential Financial Inc (PRU) stock worth over $7 Million. Details can be seen in Arthur F Ryan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Arthur F Ryan has not made any transactions after 2024-10-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Arthur F Ryan
Arthur F Ryan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Arthur F Ryan owns 4 companies in total, including Regeneron Pharmaceuticals Inc (REGN) , Citizens Financial Group Inc (CFG) , and JetPay Corp (JTPY) among others .
Click here to see the complete history of Arthur F Ryan’s form 4 insider trades.
Insider Ownership Summary of Arthur F Ryan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2024-10-01 | director |
| CFG | Citizens Financial Group Inc | 2015-05-05 | director |
| JTPY | JetPay Corp | 2012-12-28 | director |
 | | 2004-03-11 | director & Chairman & CEO and President |
Arthur F Ryan Latest Holdings Summary
Arthur F Ryan currently owns a total of 2 stocks. Among these stocks, Arthur F Ryan owns 17,582 shares of Regeneron Pharmaceuticals Inc (REGN) as of October 1, 2024, with a value of $18 Million and a weighting of 72.37%. Arthur F Ryan also owns 52,431 shares of Prudential Financial Inc (PRU) as of March 11, 2004, with a value of $7 Million and a weighting of 27.63%.
Latest Holdings of Arthur F Ryan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2024-10-01 | 17,582 | 998.23 | 17,550,880 |
| PRU | Prudential Financial Inc | 2004-03-11 | 52,431 | 127.82 | 6,701,730 |
Holding Weightings of Arthur F Ryan
Arthur F Ryan Form 4 Trading Tracker
According to the SEC Form 4 filings, Arthur F Ryan has made a total of 41 transactions in Regeneron Pharmaceuticals Inc (REGN) over the past 5 years, including 0 buys and 41 sells. The most-recent trade in Regeneron Pharmaceuticals Inc is the sale of 100 shares on October 1, 2024, which brought Arthur F Ryan around $104,878.
According to the SEC Form 4 filings, Arthur F Ryan has made a total of 0 transactions in Prudential Financial Inc (PRU) over the past 5 years. The most-recent trade in Prudential Financial Inc is the acquisition of 21,900 shares on March 11, 2004, which cost Arthur F Ryan around $996,450.
Insider Trading History of Arthur F Ryan
- 1
Arthur F Ryan Trading Performance
GuruFocus tracks the stock performance after each of Arthur F Ryan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Arthur F Ryan is -1.28%. GuruFocus also compares Arthur F Ryan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Arthur F Ryan within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Arthur F Ryan's insider trading performs compared to the benchmark.
Performance of Arthur F Ryan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5.41 | | | | | |
| Relative Return to S&P 500(%) | -7.14 | | | | | |
Arthur F Ryan Ownership Network
Arthur F Ryan Owned Company Details
What does Regeneron Pharmaceuticals Inc do?
Who are the key executives at Regeneron Pharmaceuticals Inc?
Arthur F Ryan is the director of Regeneron Pharmaceuticals Inc. Other key executives at Regeneron Pharmaceuticals Inc include SVP Commercial Marion Mccourt , VP & Controller Christopher R. Fenimore , and EVP Research Andrew J Murphy .
Regeneron Pharmaceuticals Inc (REGN) Insider Trades Summary
Over the past 18 months, Arthur F Ryan made 16 insider transaction in Regeneron Pharmaceuticals Inc (REGN) with a net sale of 1,500. Other recent insider transactions involving Regeneron Pharmaceuticals Inc (REGN) include a net sale of 9,814 shares made by Marion Mccourt , a net sale of 7,918 shares made by Bonnie L Bassler , and a net sale of 6,731 shares made by Joseph J Larosa .
In summary, during the past 3 months, insiders sold 33,514 shares of Regeneron Pharmaceuticals Inc (REGN) in total and bought 0 shares, with a net sale of 33,514 shares. During the past 18 months, 318,089 shares of Regeneron Pharmaceuticals Inc (REGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 318,089 shares.
Regeneron Pharmaceuticals Inc (REGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regeneron Pharmaceuticals Inc Insider Transactions
Arthur F Ryan Mailing Address
Above is the net worth, insider trading, and ownership report for Arthur F Ryan. You might contact Arthur F Ryan via mailing address: Citizens Financial Group, Inc, 600 Washington Boulevard, Stamford Ct 06901.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
